Amn Healthcare Stock Price, News & Analysis

AMN Healthcare (NYSE: AMN) has announced a private offering of $400.0 million in senior unsecured notes due 2031. The company plans to use the proceeds, along with cash on hand and credit facility borrowings, to redeem all of its outstanding $500.0 million 4.625% senior notes due 2027 and cover related fees and expenses.

The 2031 Notes will be offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S. As a leading healthcare talent solutions provider, AMN Healthcare served nearly 15 million patients across more than 2,100 healthcare systems in 2024, including 87% of top healthcare systems nationwide.

AMN Healthcare (NYSE:AMN), a leading healthcare talent solutions provider, reported Q2 2025 financial results with revenue of $658.2 million, down 11% year-over-year. The company posted a GAAP net loss of ($3.02) per share, primarily due to $128 million in goodwill and intangible asset impairment charges. Adjusted EPS was $0.30, down 69% from Q2 2024.

Key highlights include strong cash flow from operations of $79 million, debt reduction of $80 million, and the sale of Smart Square for $75 million. AMN Passport app reached 300,000 users. The company's Q3 2025 guidance projects revenue between $610-625 million, representing a 9-11% year-over-year decline, with adjusted EBITDA margin of 7.7-8.2%.

O.R. Staffing Solutions, a portfolio company of Argosy Healthcare Partners, has announced significant leadership changes with the appointment of Brent Bormaster as CEO, along with Mark Smith as Executive Chairman and Jerick Henley as Director to its Board.

Bormaster brings extensive experience from his previous role as President at AHS Staffing and an 18-year tenure at AMN Healthcare (NYSE: AMN) where he served as Divisional Vice President. The new leadership team, including Smith and Henley, previously collaborated in scaling and successfully exiting American Health Staffing Group (AHSG).

ORSS specializes in providing workforce solutions for operating rooms in acute care hospitals and ambulatory surgery centers, utilizing a clinician-led, operating room-centric approach known for faster onboarding and precise matching in surgical settings.

AMN Healthcare (NYSE:AMN) has released its 32nd annual physician recruiting incentives report, revealing that the average starting salary for physicians has reached $403,000. The comprehensive study shows significant salary variations across specialties, with orthopedic surgeons commanding the highest starting salary at $576,000, while pediatricians receive the lowest at $258,000.

The report highlights substantial year-over-year salary increases, with otolaryngologists seeing the largest gain of 36% to $487,000. Nurse practitioners are also experiencing rising compensation, with average starting salaries increasing 9.6% to $180,000. Additionally, physicians receive an average signing bonus of $38,315, relocation allowance of $12,619, and CME allowance of $4,073.

AMN Healthcare (NYSE:AMN), the leader in healthcare total talent solutions, has scheduled its Q2 2025 earnings conference call for Thursday, August 7, 2025, at 5:00 p.m. Eastern Time. The company will release its earnings report after market close at approximately 4:15 p.m. ET on the same day.

The call will be accessible via webcast and telephone, with registration required for dial-in access. In 2024, AMN's healthcare professionals served nearly 15 million patients across more than 2,100 healthcare systems, including 87% of top healthcare systems nationwide.

AMN Healthcare (NYSE: AMN) has announced the sale of its Smart Square® scheduling software to symplr® for $75 million, comprising $65 million upfront and a $10 million note due in 2026. The transaction includes a strategic commercial partnership between the two companies.

The partnership combines AMN's WorkWise platform's workforce planning, analytics, and AI capabilities with symplr's operational technology. This integration aims to enhance workforce optimization, scheduling, timekeeping, and administrative processes for healthcare organizations nationwide.

The collaboration allows AMN to focus on developing its WorkWise technology suite while leveraging symplr's expertise in operational software, creating a comprehensive solution for healthcare workforce management.

symplr has acquired Smart Square® scheduling software from AMN Healthcare (NYSE: AMN), enhancing its healthcare workforce management capabilities. The acquisition combines two Best in KLAS solutions, integrating Smart Square's AI-driven nurse and staff scheduling platform with symplr's existing healthcare operations software suite.

The strategic acquisition strengthens symplr's Operations Platform by adding advanced features including predictive analytics, real-time staffing adjustments, open-shift management, and nurse competency integration. Additionally, symplr and AMN Healthcare have established a commercial partnership to leverage their respective strengths in operational technology and healthcare workforce solutions.

Following the deal, AMN Healthcare will focus on developing its Workwise platform for workforce advisory, planning AI, staffing, and analytics solutions.

AMN Healthcare (NYSE: AMN), a leader in healthcare total talent solutions, has announced the appointment of Celia Huber to its Board of Directors, effective May 2, 2025. Huber, currently a Senior Partner at McKinsey & Company, brings over 30 years of experience in healthcare strategy and leadership.

As the leader of McKinsey's Board Services Practice in North America, Huber specializes in advising Fortune 500 boards on governance, succession planning, and organizational transformation. Her extensive background includes counseling healthcare systems and payors on strategy, merger integration, and risk management.

Huber currently serves on the AltaMed Foundation board and the Executive Committee of the California Business Roundtable, demonstrating her commitment to healthcare leadership and organizational governance.

A new survey by AMN Healthcare reveals a significant increase in physician appointment wait times across 15 major U.S. metropolitan areas. The average wait time has surged to 31 days, marking a 19% increase since 2022 and a 48% increase since 2004. Among specialties, Obstetrics/Gynecology has the longest average wait time at 42 days, followed by Gastroenterology (40 days) and Dermatology (36.5 days). Boston has the highest average wait time at 65 days, while Atlanta has the shortest at 12 days. The survey also found that 82% of physicians accept Medicare, but only 53% accept Medicaid. Some extreme cases include wait times of 291 days for dermatology in Portland and 231 days for obstetrics/gynecology in Boston.